Tag: Pharmaceutical industry
Pregabalin and Gabapentin: How dangerous are the painkillers? – Health
The active ingredients against anxiety, epilepsy and severe pain can lead to increased deaths, data from England shows. However, it is almost never due to the medication alone, but rather…
Pregabalin and Gabapentin: How dangerous are the painkillers? – Health
The active ingredients against anxiety, epilepsy and severe pain can lead to increased deaths, data from England shows. However, it is almost never due to the medication alone, but rather…
Sometimes you have to protect patients from themselves – health
Anyone who is sick and suffering needs support, help and comfort. Chronically ill people are particularly dependent on it. Doctors and nursing staff are rarely able to adequately meet these…
Pregabalin and Gabapentin: How dangerous are the painkillers? – Health
It sounds more like a horror story than a relevant piece of information: “This painkiller is responsible for thousands of deaths,” was the headline in a recent tabloid. More than…
Losing weight: Should health insurance companies pay for weight loss products?
The drug Wegovy has sparked a debate: losing weight with a prescription – is that the future? What speaks for it and what hurdles there are. source site
How deeply the Bayer Group is in crisis
]]> source site
Bayer: It is the last chance for Bayer – economy
Exactly 125 years ago, on March 6, 1899, the brand name “Aspirin” was registered at the patent office in Berlin. The tablet is still Bayer’s best-known product. Nine years ago,…
Bayer: Former top researcher harshly criticizes the structure and working methods of the giant corporation – WirtschaftsWoche
Bayer: Former top researcher harshly criticizes the structure and working methods of the giant company WirtschaftsWoche source site
Weight loss injections: Novo Nordisk versus Eli Lilly – Economy
It’s a big deal. And it’s just the beginning. In the 2023 financial year, the Danish company Novo Nordisk generated sales of a good 31 billion crowns, the equivalent of…
Novartis offers 2.7 billion euros for Munich biotech company Morphosys – Economy
The Swiss pharmaceutical company Novartis is reaching out to the biotech company Morphosys. The Swiss are spending 2.7 billion euros on this. Novartis is particularly interested in the promising pelabresib…